Skip to main content
. 2018 Jul 31;6:e5362. doi: 10.7717/peerj.5362

Table 1. “Best GBM-related mutations” from coding regions of SD01 and TCGA samples.

Gene Sample AA change FATHMM score SIFT score AF (Tumor) Coverage (Tumor)
EGFR SD01 RNA-seq only A702S −0.97 (CANCER) 0.01 (Del) 0.015 852
EGFR SD01 Intersection A289V −1.04 (CANCER) 0.002 (Del) 0.072 125
EGFR GBM01 Intersection G63R −1.93 (CANCER) 0.0 (Del) 0.175 296
TP53 GBM01 Intersection G105R −10.02 (CANCER) 0.0 (Del) 0.44 50
TP53 GBM02 RNA-seq only I254S −9.48 (CANCER) 0.0 (Del) 0.949 390
TSC2 GBM02 RNA-seq only V296fs 71% (pathogenic) 85.8% (Dam) 0.137 55
PTEN GBM02 Intersection D107Y −3.06 (CANCER) 0.0 (Del) 0.69 92
PTEN GBM03 Intersection R173H −6.42 (CANCER) 0.0 (Del) 0.331 173
PTEN GBM04 Intersection D326fs 88% (pathogenic) 85.8% (Dam) 0.393 146
PTEN GBM07 WXS only R130Q −5.84 (CANCER) 0.0 (Del) 0.713 190
NF1 GBM10 WXS only C622F −0.83 (CANCER) 0.01 (Del) 0.403 389

Notes:

All variants shown were included in COSMIC and in a set of 29 GBM-related genes but not dbSNP. All variants are deleterious based on scoring by SIFT and FATHMM with cancer weights. For SIFTindel and FATHMM indels, the score is given as a confidence score of the prediction. AF (Allele Fraction, tumor) shows the proportion of altered reads in tumor samples, with Coverage (tumor) being the total number of reads at the variant position.